Gemcitabine, ifosfamide, cisplatin (GIP) for the treatment of advanced non-small cell lung cancer: A phase II study of the italian oncology group for clinical research (GOIRC)

C. Boni, G. Bisagni, L. Savoldi, G. Moretti, E. Rondini, M. Sassi, A. Zadro, T. De Pas, V. Franciosi, A. Pazzola, R. Vignoli, M. C. Banzi, V. Pajetta

Research output: Contribution to journalArticle

Fingerprint Dive into the research topics of 'Gemcitabine, ifosfamide, cisplatin (GIP) for the treatment of advanced non-small cell lung cancer: A phase II study of the italian oncology group for clinical research (GOIRC)'. Together they form a unique fingerprint.

Medicine & Life Sciences